↓ Skip to main content

Should oncologists trust cannabinoids?

Overview of attention for article published in Frontiers in Pharmacology, July 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Should oncologists trust cannabinoids?
Published in
Frontiers in Pharmacology, July 2023
DOI 10.3389/fphar.2023.1211506
Pubmed ID
Authors

Ioana Creanga-Murariu, Leontina Elena Filipiuc, Magda Cuciureanu, Bogdan-Ionel Tamba, Teodora Alexa-Stratulat

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 24%
Researcher 5 17%
Student > Doctoral Student 1 3%
Other 1 3%
Professor 1 3%
Other 1 3%
Unknown 13 45%
Readers by discipline Count As %
Medicine and Dentistry 4 14%
Pharmacology, Toxicology and Pharmaceutical Science 3 10%
Biochemistry, Genetics and Molecular Biology 2 7%
Veterinary Science and Veterinary Medicine 2 7%
Agricultural and Biological Sciences 1 3%
Other 3 10%
Unknown 14 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 August 2024.
All research outputs
#3,528,846
of 26,409,992 outputs
Outputs from Frontiers in Pharmacology
#1,643
of 20,448 outputs
Outputs of similar age
#60,800
of 374,785 outputs
Outputs of similar age from Frontiers in Pharmacology
#38
of 729 outputs
Altmetric has tracked 26,409,992 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,448 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 374,785 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 729 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.